Intellia Therapeutics listed its stock on the Nasdaq exchange.
9 reports, 4 independent
Updated Fri 00:00
Mostly repetition
- Reports
- 9
- Developments
- 2
- Repetition
- 78%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Intellia Therapeutics listed its stock on the Nasdaq exchange.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Intellia Therapeutics trades on the Nasdaq exchange.1 source
Intellia Therapeutics completed its stock listing on Nasdaq.1 source
Keep exploring
The entities involved
-
Intellia Therapeutics
It is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system.
Nothing else this week.
-
Nasdaq
American fully electronic stock exchange
Related events
- Evelo Biosciences listed its stock on the Nasdaq exchange on August 1, 2026.
- Intellia Therapeutics announced it will present at a conference on September 4, 2026.
- HCW Biologics announced it is listed on the Nasdaq stock exchange.
- Iovance Biotherapeutics listed its stock on Nasdaq and received Fast Track designation from the FDA.
- Decoy Therapeutics was listed on the Nasdaq stock exchange on September 22, 2026.
Coverage
Newest first; wire copies grouped- dailypolitical.com
- tickerreport.com
- fool.com
- tickerreport.com
- dailypolitical.com
- themarketsdaily.com